Skip to main content
Home
  • Clinical Outcome Assessments
    Clinical Outcome Assessments

    What are Clinical Outcome Assessments (COAs)? What do they measure?

    Learn more about COAs
    hero_1.jpeg
    The most trusted distributor of COAs

    700+ exclusive COA distributions on behalf of their copyright owners

    hero_2.jpeg
    PROQOLID™: the largest COA database

    7,000+ COAs described in details and accessible in this unique database

  • Services
    Services

    Mapi Research Trust provides turnkey solutions for your Clinical Outcome Assessments (COAs) strategies - including COA databases, targeted literature reviews, licensing.

    Read More
    COA Databases Patient-Centered Endpoint Intelligence COA Licensing Translation and Linguistic Validation eCOA Licensing COA Repository
    hero_3.jpeg
    About ePROVIDE™

    Online access to all our services and COA databases

    hero_2_2.jpeg
    What are eBooklets?

    Find out more about this step-by-step guidance for valid digitization of COAs

  • Author Collaboration
    Author Collaboration

    Our team is dedicated to assisting authors in the daily management of their questionnaires and all derivatives, including translations and electronic versions

    Read More
    COA distribution COA copyright and protection Promotion of COAs and developers Testimonials
    hero_3_1.jpeg
    Catalog of COAs distributed by Mapi Research Trust

    800+ exclusive distributions of COAs, accessible in ePROVIDE

  • Resources
    Resources

    ACCESS all our resources on COAs and eCOA: webinars, publications, blogs. SUBSCRIBE to receive email updates.

    Read More
    Blog Publications Useful links Webinar recordings Whitepapers
    Whitepaper-Digitizing-COAs.jpg
    New whitepaper

    Digitizing COAs: A streamlined approach to approval

    hero_4_2.jpeg
    New whitepaper

    COAs and copyright: How to mitigate risks of infringement and misuse in clinical research and practice

  • News & Events
    News & Events

    Stay informed with our latest news and check all our upcoming events. SUBSCRIBE to get email updates.

    Read More
    hero_5_1.jpeg
    News
    Hero_5_2.jpeg
    Conferences
    Hero_5_3.jpeg
    Webinars
  • About us
    About us

    Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Clinical Outcome Assessments(COAs).

    Read More
    hero_6_1.jpeg
    Team

    A global team of multi-disciplinary experts

    hero_6_2.jpeg
    Experience

    Collecting & Processing Patient Centered Outcomes information for more than two decades

  • Contact
  1. Home
  2. Resources
  3. Blog
  4. Best practices to keep eCOA implementation off the critical path of clinical trial startup.

Best practices to keep eCOA implementation off the critical path of clinical trial startup

  • 29 March 2023

In every clinical trial, rapid startup is critical. If your protocol is using or considering using electronic versions of Clinical Outcome Assessments (eCOA) to capture patient data, several key steps and service areas must be coordinated simultaneously to prevent eCOA implementation from being on your study startup’s critical path and potentially delaying the overall trial.

 

Why use eCOA?

eCOA consists of digitizing the paper version of Clinical Outcome Assessments (COAs) to enable electronic capture of data. This electronic format presents numerous advantages for patient-centric drug development and decentralized trials:

  • Drive compliance in terms of patients’ completion of questionnaire information, thanks to automatic notifications and alerts in the electronic devices used to capture those data.
  • Eliminate inconsistencies often faced with paper data collection (missing, illegible, late entries).
  • Reduce burden on patients (less planning than on-site visits, willingness to answer sensitive questions).
  • Enhance monitoring of data thanks to direct centralization in real time.

What are the key steps of eCOA implementation?

First, it is critical to acknowledge that eCOA implementation is complex. Indeed, several individual service areas must come together seamlessly for eCOA to be delivered according to the target in the startup plan.

Here is a brief overview of all critical steps:

1. COA licensing

  • Identify complete list of COAs, countries and languages required for the trial.
  • Secure license agreements from copyright holders for their permission to use their COAs and derivatives.
  • Ensure study usage and application match licensing requirements.
  • Get approval of the original screenshots when relevant.

2. COA translation and linguistic validation

  • Conceptual analysis of source COA to list concepts for harmonization of translation across countries.
  • Forward and backward translation.
  • Cognitive interviews and clinician’s review.
  • Proofreading finalization and delivery of final target language version(s) and linguistic validation certificate(s).

3. Electronic migration of translations

  • Starting point with the US English final software files & screenshots ready, and final paper translations available.
  • Integration of paper translation text into software files and translation adjustments to electronic administration when needed.
  • Screenshot generation by eVendor for review by the translation provider and, in some cases, by the COA copyright holder as well.
  • Final validation of screenshots, after back and forth, and certification of translations.

4. eCOA system build and test

  • Document design based on requirements including specific details around the build of the eCOA system.
  • Screenshot generation, first of the base language and then of translations.
  • System build including rigorous software testing by the eVendor.
  • User Acceptance testing, ideally completed by an independent party as if in real-environment-like conditions.
  • Training and device shipment.

 

Any failure in any of these service areas or any failure in the way these services are coordinated together means that eCOA can quickly become the critical path for startup targets, resulting in delayed submissions, Site Initiation Visit (SIV) and patient recruitment.

uuid_7fb268af-4425-47eb-a8b7-884e714fbe4b_Figure-1-eCOA-timeline-in-the-context-of-study-startup
Figure 1: eCOA timeline in the context of study startup

How to keep eCOA off the critical path?

Even though eCOA implementation is complex, simple solutions can be implemented to mitigate the risks and to ensure seamless eCOA implementation. The key is to consider eCOA as a single project across the multiple stakeholders that are involved, to collectively review all milestones and to align on timeline.

Ideally the project should be overseen by one eCOA project manager within the sponsor’s team. Then a single project plan should be set for each service provider across all key deliverables ensuring that milestones for this plan meet the study startup targets (e.g., planned submission dates and site activation dates).

This solution involves 3 implementation stages:

1. Early COA assessment

Identify, at the protocol design stage, any potential electronic implementation risks (Challenges in licensing? Available translations? Etc.).

2. Create an eCOA implementation plan

Define the baseline project plan across all service providers that will be used to govern the eCOA implementation by the eCOA project manager. Map out all key deliverables and highlight key dependencies between service providers.

3. Execute the plan

How do you actually keep the eCOA project on track during the entire study startup lifecycle? Create an eCOA project team with members across the service areas and apply an agile-like methodology.

uuid_bc521c05-1e5e-432e-82ce-3e4d6fcd3486_eCOA-whitepaper-screenshot

For more details on the solutions to keep eCOA implementation off the critical path, read the whitepaper developed in collaboration with ICON.

 

Read the whitepaper
In this section
In this section
  • Blog
  • Publications
    • PROQOLID
    • PROLABELS
    • Literature Review
    • Intellectual Property, copyright issues, and distribution of Patient-Centered Outcomes
    • Translation & Linguistic validation
    • Therapeutic areas
      • Digestive health, gastroenterology, metabolism
      • Endocrinology
      • General
      • Gynecology
      • Hematology
      • Infectious disease, immunology, vaccines
      • Ophthalmology
      • Pain
      • Psychiatry-psychology
      • Rare Diseases
      • Respiratory
      • Rheumatology–musculoskeletal disorders
      • Urology
    • Cochrane HRQoL Methods Group
    • Development projects
    • Education
    • ERIQA/PRO harmonization
    • IQOD
  • Useful links
  • Webinar recordings
  • Whitepapers
    • Whitepaper | COAs and copyright
    • The COA licensing process: How to prepare for success
    • Whitepaper | Digitizing COAs: A streamlined approach to approval

Related information

Webinar

Keep eCOA Off the Critical Path of Clinical Trial Startup

Site Branding
    ICON plc
  • Contact
  • About Us
For Clients
  • Services
  • Resources
  • ePROVIDE™
News & Events
  • News
  • Conferences
  • Webinars
Socials
  • Linkedin

Legal Footer

  • © 2025 Mapi Research Trust
  • Disclaimer
  • Privacy
How can we help?
  • All
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption